Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/OH/Cincinnati
Updated September 2026 from ClinicalTrials.gov

Paid Clinical Trials in Cincinnati, OH

Studies commonly pay $75 to $4,500 per completed study

1,133 clinical trials are currently recruiting participants within 30 miles of Cincinnati. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

1,133studies recruiting
9+research centers nearby
4condition categories
Live from the NIH registry

Studies recruiting near Cincinnati right now

Top 25 of 1,133 recruiting studies, sorted by proximity — each links to its official registry page

A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)

Neovascular Age-related Macular Degeneration Phase 4 Interventional 188 participants sought
Cincinnati Eye Institute — Blue Ash, Ohio (9.3 mi) · Sponsor: Genentech, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT04853251)

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

High Grade Glioma, Diffuse Intrinsic Pontine Glioma Phase 2 Interventional 120 participants sought
Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio (1.1 mi) · Sponsor: Nationwide Children's Hospital
See eligibility & contact on ClinicalTrials.gov (NCT05096481)

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC) Phase 1 Interventional 604 participants sought
The Christ Hospital — Cincinnati, Ohio (1.1 mi) · Sponsor: Revolution Medicines, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06040541)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought
Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio (1.1 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06124157)

A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)

Non-Small Cell Lung Cancer Phase 2 Interventional 120 participants sought
Oncology Hematology Care Clinical Trials LLC — Cincinnati, Ohio (1.1 mi) · Sponsor: Regeneron Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT06465329)

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

Lymphoma, Large B-Cell, Diffuse Phase 2 Interventional 594 participants sought
University of Cincinnati Medical Center ( Site 0156) — Cincinnati, Ohio (1.1 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06890884)

A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction

Left Ventricular Systolic Dysfunction, Heart Failure (Pediatric) Phase 3 Interventional 117 participants sought
Cincinnati Children's Hospital Medical Center | Division of Nephrology and Hypertension — Cincinnati, Ohio (1.1 mi) · Sponsor: Bayer
See eligibility & contact on ClinicalTrials.gov (NCT07192952)

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

Colitis, Ulcerative Phase 3 Interventional 882 participants sought
Tri-State Gastroenterology Assoc — Crestview Hills, Kentucky (8.9 mi) · Sponsor: Janssen Research & Development, LLC
See eligibility & contact on ClinicalTrials.gov (NCT07196748)

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
Good Samaritan Hospital - Cincinnati — Cincinnati, Ohio (1.1 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03851445)

Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase

Acute Pancreatitis Phase 1, Phase 2 Interventional 42 participants sought
Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio (1.1 mi) · Sponsor: St. Jude Children's Research Hospital
See eligibility & contact on ClinicalTrials.gov (NCT04195347)

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma Phase 2 Interventional 81 participants sought
Good Samaritan Hospital - Cincinnati — Cincinnati, Ohio (1.1 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05112601)

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

Diffuse Intrinsic Pontine Gliomas (DIPG), Progressive DIPG Phase 2 Interventional 60 participants sought
Cincinnati Children's Hospital — Cincinnati, Ohio (1.1 mi) · Sponsor: Nationwide Children's Hospital
See eligibility & contact on ClinicalTrials.gov (NCT06838676)

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma Phase 2 Interventional 40 participants sought
Ohio State University-Telemedicine — Cincinnati, Ohio (1.1 mi) · Sponsor: Sameek Roychowdhury
See eligibility & contact on ClinicalTrials.gov (NCT06906562)

A Study of T3011 in Patients With BCG-Unresponsive NMIBC or BCG-Exposed, Chemotherapy-Unresponsive NMIBC

Nonmuscle-invasive Bladder Cancer Phase 2 Interventional 160 participants sought
University of Cincinnati Medical Center — Cincinnati, Ohio (1.1 mi) · Sponsor: ImmVira Pharma Co. Ltd
See eligibility & contact on ClinicalTrials.gov (NCT06971614)

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

Non-Small Cell Lung Cancer (NSCLC) Phase 3 Interventional 750 participants sought
Local Institution - 0383 — Cincinnati, Ohio (1.1 mi) · Sponsor: Bristol-Myers Squibb
See eligibility & contact on ClinicalTrials.gov (NCT07361510)

Optimizing Beta Blocker Dosage in Women While Using the Wearable Cardioverter Defibrillator

Cardiomyopathies, Heart Failure N/A Interventional 300 participants sought
TriHealth Hatton Research Institute — Cincinnati, Ohio (1.1 mi) · Sponsor: Zoll Medical Corporation
See eligibility & contact on ClinicalTrials.gov (NCT04504188)

MEKTOVI® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma

Adamantinous Craniopharyngioma, Recurrent Adamantinomatous Craniopharyngioma Phase 2 Interventional 38 participants sought
Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio (1.1 mi) · Sponsor: Nationwide Children's Hospital
See eligibility & contact on ClinicalTrials.gov (NCT05286788)

A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment of Cytomegalovirus (CMV) Infection in Children and Adolescents Who Have Received a Hematopoietic Stem Cell Transplant (HSCT) or a Solid Organ Transplant (SOT)

Cytomegalovirus (CMV) Phase 3 Interventional 80 participants sought
Cincinnati Children's Hospital Medical Center - PIN — Cincinnati, Ohio (1.1 mi) · Sponsor: Takeda
See eligibility & contact on ClinicalTrials.gov (NCT05319353)

Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus

Systemic Lupus Erythematosus of Childhood (Disorder) N/A Interventional 175 participants sought
Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio (1.1 mi) · Sponsor: Michigan State University
See eligibility & contact on ClinicalTrials.gov (NCT06232304)

BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)

Limited Stage Small Cell Lung Cancer Phase 2 Interventional 250 participants sought
Oncology Hematology Care — Cincinnati, Ohio (1.1 mi) · Sponsor: SCRI Development Innovations, LLC
See eligibility & contact on ClinicalTrials.gov (NCT06773910)

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer Phase 3 Interventional 590 participants sought
TriHealth Cancer & Blood Institute Research — Cincinnati, Ohio (1.1 mi) · Sponsor: Revolution Medicines, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06881784)

Child Bipolar Network Ketogenic Diet Approach to Bipolar Disorder in Adolescents

Bipolar Disorder (BD), Bipolar Disorder NOS N/A Interventional 80 participants sought
University of Cincinnati College of Medicine — Cincinnati, Ohio (1.1 mi) · Sponsor: University of California, Los Angeles
See eligibility & contact on ClinicalTrials.gov (NCT06920940)

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Endometrial Cancer Phase 3 Interventional 600 participants sought
Research Site — Cincinnati, Ohio (1.1 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06989112)
Actively enrolling

Studies you may be able to join near Cincinnati

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Cincinnati

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

CTI Clinical Trial & Consulting Clinical Research Center

★ 4.5
1775 Lexington Ave, Cincinnati, OH 45212
(513) 281-3868
"My experience with all my studies & staff have been excellent!!!"
— Burton James, 5★

Lindner Clinical Trial Center

★ 4.8
2123 Auburn Ave Suite 424, Cincinnati, OH 45219
(513) 585-1777
"Very professional and caring ❤"
— Michelle O, 5★

Velocity Clinical Research

★ 4.6
2230 Auburn Ave Level B, Cincinnati, OH 45219
(513) 381-4100

Clinical Research Center

3333 Burnet Ave, Cincinnati, OH 45229
(513) 636-4412

Cincinnati Children's Clinical Sciences Pavilion (Location T)

★ 5.0
240 Albert Sabin Way Ste t9.478, Cincinnati, OH 45229
(513) 636-4200

UC Infectious Disease Clinical Research

200 Albert Sabin Way, Cincinnati, OH 45220
(513) 584-6617

Clinical Research Consultants

3308 Jefferson Ave, Cincinnati, OH 45220
(513) 383-0914

Consultants For Clinical Research

2925 Vernon Pl #200, Cincinnati, OH 45219
(513) 872-4549

CTI Clinical Trial Services, Inc.

★ 3.0
100 E Rivercenter Blvd, Covington, KY 41011
(513) 598-9290
"Nice looking building, so took a photo from Roebling bridge."
— Atul Nautiyal, 4★

Clinical trials in Cincinnati: what's recruiting

The Cincinnati area currently has 1,133 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Cincinnati, the most active research areas are:

  • Cancer & Oncology15 studies
  • Heart & Vascular3 studies
  • Immune & Skin2 studies
  • Brain & Mental Health1 studies

Every listing shows the study phase, the recruiting site and its distance from Cincinnati, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Cincinnati

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Cincinnati participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Cincinnati pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Cincinnati?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Cincinnati safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How often do new paid studies open in Cincinnati?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Cincinnati.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Cincinnati typically complete one or two studies per year.

Paid clinical trials near Cincinnati

Other metros within reach

Dayton, OH308 Lexington, KY477 Louisville, KY557 Columbus, OH1,348 Indianapolis, IN928 Fort Wayne, IN118 Huntington, WV55 Lafayette, IN36

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Cincinnati Heart Failure in Cincinnati Chronic Kidney Disease (HealthMatch) in Cincinnati Bladder Issues Due To Spinal Cord Injury in Cincinnati All conditions

More of OH

Cleveland1,412 Columbus1,348 Lorain1,305 Akron393 Dayton308 Canton304 Toledo211 Youngstown81

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts